Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 05 Jun 2023 for Denali Therapeutics Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Douglas G. Cole: trading record in brief
Douglas G. Cole, listed as board member, appears in our data through filings on Denali Therapeutics Inc. shares, published by SEC (Form 4). Between 1 June 2021 and 1 June 2023, the trades on record add up to 4 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 5 June 2023: a share grant, in Denali Therapeutics Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Douglas G. Cole
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
4,216 shares0Common StockSEC:0001714899-23-000093:0
5,986 shares0Common StockSEC:0001714899-22-000095:0
2,074 shares0Common StockSEC:0001209191-21-038374:0
3,253 shares0Common StockSEC:0001209191-21-038035:0
4 of 4 declarations
